Stay updated on NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a backend or template update. No study content or data were modified as part of this change.
    Difference
    0.0%
    Check dated 2026-05-14T23:11:01.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3 on the page, indicating a minor front-end/site update. No study data or user-facing content was modified.
    Difference
    0.0%
    Check dated 2026-04-30T16:43:37.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:28:02.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    - Added Squamous cell carcinoma of the head and neck and Cutaneous neuroendocrine carcinoma to the study's conditions.
    Difference
    0.1%
    Check dated 2026-04-02T00:29:28.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision history updated: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-25T21:00:08.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:52:35.000Z thumbnail image

Stay in the know with updates to NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page.